Evaluation of the efficacy and safety of original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) in CD34(+) peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors


Sivgin S., Karakuş E., Keklik M. , ZARARSIZ G. , Solmaz M., Kaynar L. , ...More

TRANSFUSION AND APHERESIS SCIENCE, vol.54, no.3, pp.410-415, 2016 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Article
  • Volume: 54 Issue: 3
  • Publication Date: 2016
  • Doi Number: 10.1016/j.transci.2016.03.003
  • Title of Journal : TRANSFUSION AND APHERESIS SCIENCE
  • Page Numbers: pp.410-415

Abstract

Objectives and Aim: In this study, we aimed to compare the potency of different G-CSF agents including original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) on CD34(+) cell mobilization in patients that underwent allogeneic hematopoietic stem cell transplantation (alloHSCT).